Plavix copycat pops up in Europe

admin — Fri, 09 May 2008 06:59:58 -0400

Call it generic Whac-a-Mole. Sanofi-Aventis and Bristol-Myers Squibb have bludgeoned copycat Plavix in the U.S., but competition is now popping up in Europe. Swiss drugmaker Schweizerhall Holding Read more...

AMA calls for tighter DTC regulation

admin — Fri, 09 May 2008 06:59:57 -0400

We all expected Democrats to rake DTC ads over the coals during yesterday's hearing before the House Energy and Commerce Committee's oversight arm. We expected Chairman Bart Stupak to call for Read more...

Silver lining to Big Pharma's cloud?

admin — Fri, 09 May 2008 06:59:56 -0400

Some people see the Big Pharma glass as half-full instead of the alternative. In an investor's-eye look at the industry, Kiplinger ticks off the usual criticisms: patent expirations, tough generics Read more...

U.K. pharma intensifies self-policing rules

admin — Fri, 09 May 2008 06:59:55 -0400

U.S. lawmakers aren't the only ones toughening up on pharma. In the U.K., the industry itself is strengthening its code. The Association of the British Pharmaceutical Industry is adding rules on Read more...

Group wants Ortho patch withdrawn

admin — Fri, 09 May 2008 06:59:54 -0400

We've all heard the safety warnings about the Ortho-Evra birth control patch and its link to Read more...

SPOTLIGHT: Heparin prices double since recalls

admin — Fri, 09 May 2008 06:59:52 -0400

Since Baxter recalled virtually all its heparin products on reports of severe reactions and deaths, the price for the blood thinner has doubled. The sole U.S. supplier, APP Pharmaceuticals, says Read more...

ALSO NOTED: Apotex assails Canadian goodwill drug program; Amgen CEO: "I felt real economic pain";

admin — Fri, 09 May 2008 06:59:50 -0400

> After winning a bid to produce and ship generic AIDS drugs to Rwanda, Apotex says it won't participate in the goodwill program again unless the Canadian government simplifies the process. Read more...

GSK accused of monopolizing Wellbutrin

admin — Thu, 08 May 2008 06:59:57 -0400

Did GlaxoSmithKline try to monopolize the Wellbutrin market? A lawsuit now certified as class-action says so. The plaintiffs accuse GSK of artificially boosting Wellbutrin prices by fibbing to the Read more...